Fractal's AI Boom: Surging Profits Point to a New Era of Enterprise AI

MUMBAI, India – July 23, 2026 – In a powerful signal that enterprise artificial intelligence has moved from experimental curiosity to a core business imperative, AI services firm Fractal Analytics Ltd has posted remarkable first-quarter financial results for fiscal year 2027. The company reported a 92% surge in year-on-year net income, reaching Rs 72.3 Cr, on the back of a 20% rise in operating revenue to Rs 912.5 Cr.

This robust performance was overwhelmingly powered by skyrocketing demand in the Healthcare and Life Sciences (HLS) and Banking, Financial Services, and Insurance (BFSI) sectors. However, a notable 22% contraction in its Technology, Media, and Telecom (TMT) business reveals a more complex narrative beneath the headline numbers—one that reflects the strategic pivots required to thrive in the rapidly maturing AI landscape.

The Engine of Growth: From Healthcare to Finance

Fractal's explosive profit growth is a clear indicator of a market-wide shift. The company's Healthcare and Life Sciences vertical grew by an astonishing 69% year-on-year, becoming its second-largest industry segment. The BFSI sector also showed formidable strength with 36% growth, demonstrating how heavily regulated industries are now aggressively embedding AI into their core operations.

This performance aligns with broader market analysis identifying 2026 as an “inflection year” for enterprise AI, where spending is shifting decisively from isolated pilot projects to full-scale, production-grade deployments. As Srikanth Velamakanni, Group CEO and Executive Vice-Chairman of Fractal, noted, “Enterprises are putting real transformation budgets behind AI now and we're seeing it directly in the size of the deals coming to us.”

Independent research corroborates this trend, with firms like Gartner forecasting total worldwide AI spending to approach $2.6 trillion in 2026, a 47% annual increase. A recent survey found that 86% of enterprises plan to increase their AI budgets this year, with nearly two-thirds now actively using AI in their daily operations. Fractal’s Net Revenue Retention of 117% further validates this, indicating that existing clients are not just renewing their contracts but significantly expanding their investment, a hallmark of AI initiatives delivering tangible value and moving deeper into the enterprise.

A Tale of Two Sectors: The TMT Anomaly

While most of its portfolio thrived, Fractal’s 22% revenue decline in the TMT sector initially appears jarring. However, this dip seems to be an anomaly driven by client-specific events rather than a symptom of a wider market slowdown. Velamakanni clarified the context behind the numbers, stating, “TMT was the drag on our headline growth this quarter. Excluding TMT, our business grew 35% year on year, which is a better read on the underlying demand we're seeing.”

This explanation is supported by extensive market data. While Fractal faced headwinds from a client entering a joint venture and another undergoing a major reorganization, the broader TMT and IT sectors are in the midst of an AI-fueled investment boom. Global IT spending is projected to exceed $6 trillion in 2026, with the largest hyperscale tech companies alone planning to invest a combined $725 billion in AI capital expenditures this year. This divergence highlights a crucial lesson for the modern economy: even in a booming market, corporate success depends on navigating specific client relationships and internal business dynamics.

Navigating AI's New Geopolitical and Technical Terrain

Beyond pure financial performance, Fractal’s results and strategy reflect a keen awareness of the new, complex systems governing technology. Velamakanni pointed to two critical trends shaping client needs: data sovereignty and the proliferation of open-weight AI models. “As data sovereignty becomes a bigger priority for governments and enterprises, and as open-weight models keep improving, clients need a partner who can work across models and infrastructure,” he said.

This observation cuts to the heart of the next phase of AI adoption. The rise of sovereign AI—where nations prioritize control over their own data and AI capabilities—is creating significant regulatory pressure. Enterprises can no longer treat data as a borderless asset. In response, AI governance has become one of the fastest-growing budget items for corporations, now consuming up to 12% of total AI spending as they race to ensure their deployments are secure, ethical, and compliant. This environment favors partners like Fractal that offer the flexibility to operate across different cloud environments and AI models, whether proprietary or open-source, ensuring clients can meet local regulations without sacrificing performance.

Beyond Services: Building an Innovation Ecosystem

Perhaps the most telling aspect of Fractal’s strategy is its deep investment in building a durable, defensible innovation ecosystem that extends far beyond consulting services. The company dedicates over 6% of its revenue to AI research and development—a significant commitment aimed at creating proprietary intellectual property and moving beyond a purely headcount-driven business model.

At the center of this strategy is Cogentiq, Fractal’s flagship agentic AI platform. Launched in 2025, Cogentiq is designed to empower subject matter experts within an enterprise—not just data scientists—to build and deploy their own AI agents using a low-code interface. This democratizes AI, allowing intelligence to be embedded directly into daily workflows across finance, HR, and customer service.

The company’s R&D has also spawned powerful, specialized AI models. Vaidya.ai, a multi-modal “ChatGPT for healthcare,” has demonstrated remarkable capabilities, outperforming leading models on medical benchmarks and scoring 83% on India's postgraduate medical entrance exam. As part of the national India AI Mission, it represents a tangible effort to enhance healthcare accessibility. Another innovation, PiEvolve, is an advanced agentic engine for autonomous machine learning, designed to accelerate scientific discovery.

This focus on building and nurturing IP is best exemplified by the success of Qure.ai. Incubated and spun out by Fractal, Qure.ai has become a global leader in medical imaging AI, deploying its technology in over 20 countries to help rapidly diagnose conditions like tuberculosis and lung cancer. This model—of incubating ideas, building them into powerful solutions, and spinning them out into independent businesses—shows a company building systems not just for corporate profit, but for broader community well-being.